Vanderson G. Rocha
Advanced in Pure Red Cell Aplasia

Vanderson G. Rocha

Av. Dr. Enéas Carvalho De Aguiar, 255 Cerqueira César, 05403- 000, 
Sao Paulo, SP, BR 
Advanced in Pure Red Cell Aplasia
Av. Dr. Enéas Carvalho De Aguiar, 255 Cerqueira César, 05403- 000, 
Sao Paulo, SP, BR 
OverviewLocationsClinical Research

Overview

Vanderson Rocha practices in Sao Paulo, Brazil. Rocha is rated as an Advanced expert by MediFind in the treatment of Pure Red Cell Aplasia. Their top areas of expertise are Graft Versus Host Disease (GvHD), Leukemia, Anemia, Bone Marrow Transplant, and Splenectomy.

Their clinical research consists of co-authoring 354 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 3 articles in the study of Pure Red Cell Aplasia.

Locations

Av. Dr. Enéas Carvalho De Aguiar, 255 Cerqueira César, 05403- 000, Sao Paulo, SP, Brazil

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase 3, Randomized, Open-label, Multicenter Study Comparing Ponatinib Versus Imatinib, Administered in Combination With Reduced-Intensity Chemotherapy, in Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)
A Phase 3, Randomized, Open-label, Multicenter Study Comparing Ponatinib Versus Imatinib, Administered in Combination With Reduced-Intensity Chemotherapy, in Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)
Enrollment Status: Active_not_recruiting
Publish Date: October 15, 2025
Intervention Type: Drug
Study Drugs: Ponatinib, Imatinib, Vincristine, Dexamethasone, Cytarabine, Methotrexate, Prednisone
Study Phase: Phase 3
A Multicenter, Randomized, Phase III Registration Trial of Transplantation of NiCord®, Ex Vivo Expanded, UCB-derived, Stem and Progenitor Cells, vs. Unmanipulated UCB for Patients With Hematological Malignancies
A Multicenter, Randomized, Phase III Registration Trial of Transplantation of NiCord®, Ex Vivo Expanded, UCB-derived, Stem and Progenitor Cells, vs. Unmanipulated UCB for Patients With Hematological Malignancies
Enrollment Status: Completed
Publish Date: April 06, 2025
Intervention Type: Drug, Other
Study Drug: Omidubicel
Study Phase: Phase 3
Randomized, Double-Blind Clinical Trial of Ruxolitinib in Patients With Acute Respiratory Disorder Syndrome Due to SARS-CoV-2 Infection
Randomized, Double-Blind Clinical Trial of Ruxolitinib in Patients With Acute Respiratory Disorder Syndrome Due to SARS-CoV-2 Infection
Enrollment Status: Terminated
Publish Date: April 08, 2021
Intervention Type: Other, Drug
Study Phase: Phase 2/Phase 3
View 2 Less Clinical Trials

354 Total Publications

STARComm Scalably Detects Emergent Modules of Spatial Cell-Cell Communication in Inflammation and Cancer.
STARComm Scalably Detects Emergent Modules of Spatial Cell-Cell Communication in Inflammation and Cancer.
Journal: bioRxiv : the preprint server for biology
Published: August 20, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Rocha's expertise for a condition
ConditionClose
View All 8 Distinguished Conditions
View All 22 Advanced Conditions
View All 85 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile